Core Insights - The article emphasizes the importance of looking beyond surface-level growth in investments, suggesting that deeper analysis is necessary to uncover true value and risks [1]. Company Analysis - The author has 20 years of experience in life science, technology, and momentum stocks, indicating a strong background in analyzing various sectors [1]. - The focus is on interpreting financial statements in the context of management strategy and execution, which is crucial for developing risk-adjusted investment theses [1]. - A disciplined approach to valuation and downside risk assessment is highlighted, suggesting that understanding the balance sheet and competitive positioning is essential for investors [1]. Financial Analysis - The author is a Certified Management Accountant, which provides a rigorous accounting-based perspective on financial analysis, cost structures, and performance measurement [1]. - The analysis aims to bridge the gap between market perception and underlying fundamentals, indicating a thorough examination of both financial statements and management communications [1].

分组1: United Health - United Health has seen a significant decline of 35% this year, making it the worst performer in the Dow [1] - Regulatory headwinds and decreasing margins are challenges that the company must navigate, especially with a new CEO in place [1][2] - The company is expected to stabilize over time, similar to the turnaround seen with CVS [2] 分组2: Salesforce - Salesforce is down 20% for the year, while the S&P has increased by 17%, but it has recently rebounded by 15% this month [3] - There is optimism that AI will enhance Salesforce's business rather than harm it, with expectations for subscription growth [4] - The company is trading at a low valuation of 16 times cash, which has not been seen in many years, indicating potential for recovery [4] 分组3: Amazon - Amazon's stock is up around 6% this year but is underperforming compared to other major tech companies [5] - The company is currently trading at 12.5 times cash flow, below its historical average of 15, suggesting potential for valuation improvement [6] - Amazon benefits from various tailwinds, including its performance in the K-shaped retail economy and strong growth in AWS [7] - Robotics and advertising are additional growth areas that could enhance margins and efficiency for Amazon [8] - The custom silicon projects within AWS are expected to provide competitive advantages in AI efficiency [9][10] - Amazon's diverse capabilities and strategic investments position it well for future growth, making it a favorable investment opportunity [11][12]

Core Viewpoint - Renowned investor Michael Burry considers Molina Healthcare a premier investment opportunity, likening it to Warren Buffett's acquisition of Geico, but with a less risky profile and better business prospects due to its focus on Medicaid programs [1][2]. Company Analysis - Molina Healthcare has impressive growth potential and a history of high returns on invested capital, with Burry stating it has a clearer path to significant double-digit long-term growth than Apple [2]. - The company operates in a profitable niche within the health insurance sector, focusing on Medicaid and utilizing an efficient, agent-free business model [3]. - Under CEO Joe Zubretsky's leadership, Molina has undergone a significant turnaround, including stock buybacks and conservative accounting practices [3]. Market Performance - Despite a recent drop in MOH stock price and challenges in the health insurance environment, Burry remains optimistic about the company's future [3]. - Molina Healthcare shares were reported to be up 4.16% at $173.46 during midday trading [4]. Investment Perspective - Burry suggests that MOH stock could be a generational buy if it falls below $100, citing the company's strong loss ratio, expense ratio, win rate, and conservative accounting as key strengths [4].

Core Viewpoint - Renowned investor Michael Burry considers Molina Healthcare a premier investment opportunity, likening it to Warren Buffett's acquisition of Geico, and suggests it has a less risky profile with better business prospects due to its focus on Medicaid programs [1][2]. Company Overview - Molina Healthcare has demonstrated impressive growth potential and a history of high returns on invested capital, with Burry expressing a strong belief in its long-term growth prospects [2]. - Under CEO Joe Zubretsky's leadership, Molina has undergone a significant turnaround, including stock buybacks and conservative accounting practices [3]. Market Position - Despite a recent decline in MOH stock price and challenges in the health insurance sector, Burry remains optimistic about Molina's business model, which he describes as a "profitable niche" in a complex political landscape [3]. - Burry believes that Molina's focus on Medicaid and its efficient, agent-free business model positions it favorably within the industry [3]. Investment Potential - Burry predicts that MOH stock could potentially drop below $100 due to federal budget concerns, which he considers a "generational buy" opportunity at that price [4]. - He highlights Molina's superior loss ratio, expense ratio, win rate, and conservative accounting as key strengths that make it an attractive investment [4].

Core Insights - Artisan Partners' "Artisan Value Fund" reported a positive performance in Q3 2025, with returns of 0.83%, 0.91%, and 0.90% for its Investor Class, Advisor Class, and Institutional Class, respectively, against a 5.33% return for the Russell 1000 Value Index [1] Company Analysis - Elevance Health, Inc. (NYSE:ELV) is highlighted as a key stock in the Artisan Value Fund's portfolio, with a one-month return of 5.28% and a 52-week loss of 5.56%, closing at $348.38 per share with a market capitalization of $77.42 billion on December 29, 2025 [2] - The fund made a strategic decision to purchase Elevance Health, swapping it for Cigna, as both companies operate in the health insurance sector but have different business mixes. Elevance is noted for its diverse offerings in commercial, Medicare Advantage, and Medicaid, while Cigna has a larger pharmacy benefits management (PBM) business [3] - The investment case for Elevance is based on the expectation that its currently depressed earnings will recover as pricing adjusts to rising costs, with shares trading under 10X expected earnings per share compared to a 10-year average of 16X [3]

Core Insights - Elevance Health, Inc. (NYSE:ELV) is currently viewed as one of the best affordable healthcare stocks to buy, despite a recent downgrade by Deutsche Bank from Buy to Hold, with a price target reduction from $332 to $320 [1] - Following disappointing Q2 earnings, Elevance Health's stock dropped by 18.66%, although BofA raised its price target from $370 to $385 while maintaining a Neutral rating, indicating higher peer multiples [2] Management and Governance - Elevance Health's board appointed Amy Schulman as an independent director, effective January 12, 2026, who will serve on the Audit and Finance Committees, bringing expertise in regulatory strategy and healthcare innovation [3] - The appointment of Schulman is part of Elevance Health's strategy for board refreshment, aiming for independent, diverse, and future-focused leadership aligned with stakeholder priorities [4] Product and Service Expansion - Elevance Health announced the expansion of its Virtual Assistant, a digital tool designed to help members navigate their benefits and access care, available through the Sydney Health app and affiliated health plan websites [5] Business Segments - Elevance Health operates through several segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other, with the Health Benefits segment providing a range of health plans and services, and CarelonRx managing pharmacy services [6]

Core Argument - Influential figures like John Oliver and Suze Orman are urging older adults to reconsider their Medicare Advantage (MA) plans, highlighting significant flaws in the system [3][5]. Group 1: Criticism of Medicare Advantage - John Oliver criticized MA in a 31-minute segment, describing it as "woefully insufficient," with issues such as denials, delays, and high costs to taxpayers [3]. - Oliver accused major insurers of inflating patient risk scores to increase federal payments and using restrictive networks to limit care [3][4]. - Suze Orman warned that major insurers are terminating or consolidating plans for 2026, which could leave older adults vulnerable to unexpected changes in premiums, networks, and benefits [5]. Group 2: User Experience and Affordability - Despite criticisms, some MA users report satisfaction with their plans, citing low annual copay costs, with one user stating they have never spent more than $200 or $300 in a year [6].

Core Insights - Many seniors anticipate turning 65 for Medicare eligibility, but Medicare does not cover all health-related services, leading to potential financial surprises for retirees [1][5] - Long-term care is a significant expense that Medicare does not cover, which can lead to financial difficulties if not planned for [2][3] Long-term Care Costs - Long-term care costs are rising, and Medicare does not cover these expenses as they are not considered medical in nature [3] - Average long-term care costs in 2024 include: - Home health aide: $77,792 per year - Assisted living: $70,800 per year - Nursing home with shared room: $111,325 per year - Nursing home with private room: $127,750 per year [6][4] Financial Planning for Long-term Care - It is crucial for retirees to have a plan for long-term care to avoid financial upheaval, as Medicare will not provide coverage [5][7] - Options for funding long-term care include boosting retirement savings, with some individuals relying on large IRA or 401(k) balances [7] - Retirees should consider that their savings may diminish over time, especially if long-term care is needed later in retirement [8]

Company Overview - Khaveen Investments is a global Investment Advisory Firm focused on serving the investment needs of high-net-worth individuals, corporations, associations, and institutions [1] - The firm is a registered investment adviser with the Securities Exchange Commission (SEC) [1] - It offers a range of services including market and security research, business valuation, and wealth management [1] Investment Strategy - The flagship Macroquantamental Hedge Fund maintains a diversified portfolio with exposure to hundreds of investments across various asset classes, geographies, sectors, and industries [1] - The investment approach integrates top-down and bottom-up analysis, utilizing three core strategies: global macro, fundamental, and quantitative [1] Core Expertise - Khaveen Investments specializes in disruptive technologies that are transforming modern industries [1] - Key focus areas include Artificial Intelligence, Cloud Computing, 5G, Autonomous and Electric Vehicles, FinTech, Augmented and Virtual Reality, and the Internet of Things (IoT) [1]

Rep. Jasmine Crockett (D-Texas) warned that millions of Americans could face skyrocketing health insurance costs as key Affordable Care Act subsidies are set to expire at the end of 2025.Crockett Says Millions Face Premium SpikeCrockett warned Friday that the nation is approaching a "health care cliff" as enhanced ACA premium tax credits near expiration, arguing Republicans and President Trump have not offered a plan to prevent rising monthly bills."People are really, really scared about what we know is abo ...